Resources for Food and Drug Administration (FDA)

Ahead of the Bell: FDA reconsiders diabetes drugs

money.cnn.com

Government regulators are reconsidering how they approve diabetes drugs. They were criticized last year for their handling of heart risks connected with a widely used GlaxoSmithKline pill.

The Food and Drug Administration will hear from diabetes experts, cardiologists and statisticians at a two-day meeting that begins Tuesday. A panel of outside experts are expected to weigh-in on whether drug companies should be required to show that their drugs reduce heart problems and death to win FDA approval.

If FDA adopts such a standard, companies like GlaxoSmithKline, Merck & Co. Inc. and Takeda Pharmaceuticals could be forced to conduct expensive, multi-year studies previously not required of diabetes medicines.

View the Resource

Share or bookmarklet this web page at: